Bruker (BRKR) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Bruker Corporation  (NASDAQ: BRKR)
 

Bruker Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bruker Corporation inventory turnover ratio, the Bruker Corporation's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.65 in the second quarter 2026, yet the ratio remained below the average, as BRKR's market remain challenging.Average inventory processing period, for the Bruker in Jun 30 2026 quarter, has decreased to 221 days, compare to 224 days, in the Mar 31 2026 quarter.

Within Healthcare sector 239 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1690, from total ranking in the first quarter 2026 at 1854.

BRKR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bruker Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BRKR Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -8.06 % 0.45 % 2.51 % -1.95 % 3.61 %
Y / Y Cost of Sales Growth -3.76 % 8.05 % 8.57 % 8.09 % 5.53 %
Inventory Turnover Ratio (TTM) 1.65 1.63 1.61 1.58 1.54
BRKR's Total Ranking # 1690 # 1854 # 1751 # 1763 # 1767
Average inventory processing period 221 223 227 231 237
Seq. Inventory Growth -0.12 % 2.46 % -8.52 % -1.78 % 9.12 %
Seq. Cost of Sales Growth -4.63 % -16.1 % 9.77 % 9.57 % 7.07 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 14
Healthcare Sector # 240
Overall Market # 1690

Inventory Turnover Ratio Statistics
High Average Low
2.02 1.69 1.08
(Mar 31 2016)   (Mar 31 2012)



BRKR Company Profile >> Back to BRKR Efficiency Comparisons >> Compare BRKR Inventory Turnover Ratio to its Competitors

Financial Statements
Bruker's Inventories $ 1,120 Millions Visit BRKR's Balance sheet
Bruker's Cost of Revenues TTM $ 1,875 Millions Visit BRKR's Income Statement
What are BRKR's Sales? Visit BRKR's Sales by Segment

Other Inventory Turnover Ratios
Bruker's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BRKR's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BRKR's Competitors
Inventory Turnover Ratio for BRKR's Suppliers
Inventory Turnover Ratio for BRKR's Customers

You may also want to know
BRKR's Sales Growth Rates BRKR's Pe Price to earnings ratio BRKR's Receivables Turnover Ratio BRKR's Stock Quote
BRKR's Net Income Growth Rates BRKR's Ps Price to Sales ratio BRKR's Sales per Employee BRKR's Asset Turnover Ratio
BRKR's Net Margin BRKR's Pb Price to Book ratio BRKR's Financial Strength Ratios BRKR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Abbvie Inc   3.66 $ 18,365.000  Millions$ 5,016  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Baxter International Inc   3.46 $ 8,020.000  Millions$ 2,317  Millions

Date modified: 2026-09-11T09:46:17+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.